Company & Sponsor Intelligence
Hospital de Clinicas de Porto Alegre
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials8
Recruiting0
Completed4
Countries1
Therapeutic footprint
adhdbipolar_disorderpain_neuropathy
Indexed studies
NCT01705613Cost-effectiveness of the Treatment of Attention Deficit/Hyperactivity Disorder With Methylphenidate Immediate-release in Brazil
adhd · BrazilCOMPLETED
adhd · BrazilCOMPLETED
NCT02195271Neuroplasticity:Melatonin and Transcranial Current Stimulation in Healthy Subjects.
pain_neuropathy · BrazilPHASE2
pain_neuropathy · BrazilPHASE2
NCT03946787EMDR in Adolescents With Bipolar Disorder and History of Trauma
bipolar_disorder · BrazilNA
bipolar_disorder · BrazilNA
NCT02580890Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
adhd · BrazilNA
adhd · BrazilNA
NCT01747070Effect of Cranial Stimulation and Acupuncture on Pain, Functional Capability and Cerebral Function in Osteoarthritis
pain_neuropathy · BrazilNA
pain_neuropathy · BrazilNA
NCT03326427Group Dialectical Behavior Therapy as add-on Treatment for Adults With Attention Deficit/Hyperactive Disorder
adhd · BrazilNA
adhd · BrazilNA
NCT02737020Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder
adhd · BrazilPHASE4
adhd · BrazilPHASE4
NCT02737033Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder
adhd · BrazilPHASE4
adhd · BrazilPHASE4
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →